Pharma Stocks
-
NewAmsterdam Pharma (NAMS) Stock Looks Above Fair Value After Its 139% Run
NewAmsterdam Pharma has delivered a powerful long term share price gain, yet the recent pullback raises a sharper question for…
Read More » -
Indian Pharma Stocks Shielded From US Tariffs Deserve A Closer Look
Tariffs on Indian exports are being rewritten in real time, and that reshuffle is quietly creating pockets of risk and…
Read More » -
India New Zealand Trade Deal Opens A New Route For Supriya Lifescience Stock
A new India–New Zealand free trade deal is about to switch on a fresh trade lane, and export oriented pharma…
Read More » -
How Investors May Respond To Amneal Pharmaceuticals (AMRX) FDA Approval Launch
Amneal Pharmaceuticals reported that the FDA approved its lanreotide injection 120 mg/0.5 mL as a sterile, single dose prefilled syringe,…
Read More » -
Is Long Term Avexitide Supply Altering The Investment Case For Amylyx Pharmaceuticals (AMLX)?
Amylyx Pharmaceuticals disclosed past agreements with Bachem Americas and a term sheet with Polypeptide Group to supply avexitide from 2028,…
Read More » -
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here’s Why
Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $508.34, moving -1.55% from the previous trading session. The stock’s…
Read More » -
What Does Trade Desk (TTD) Gain From Its New Pharma Analytics Push?
Trade Desk (NasdaqGM:TTD) expanded its healthcare-focused partnerships with Veeva Crossix and IQVIA Digital, adding deeper analytics for pharma advertisers. The…
Read More » -
Could Royalty Pharma’s (NASDAQ:RPRX) Story Be Changing Fast?
Highlights Royalty Pharma draws attention across the healthcare market. Quarterly figures showed stronger-than-expected earnings per share. Financial activity and royalty…
Read More » -
Amylyx Pharmaceuticals (AMLX) Signs Avexitide Supply Deals, Is The Stock Fully Priced?
Amylyx Pharmaceuticals (AMLX) drew fresh attention after signing long-term manufacturing arrangements for its avexitide drug substance with Bachem Americas and…
Read More » -
Is Eli Lilly (LLY) A Bargain Following Fresh Obesity Drug Data?
Eli Lilly (LLY) just put fresh clinical data at the center of its story, highlighting new results for obesity and…
Read More »